natgillin/translations-raw huggingface dataset:
v zvezi s proračunsko podporo zagotoviti, da bodo jasno opredeljena posebna merila za plačila in da bodo poročila delegacij vsebovala strukturiran in formaliziran prikaz napredka pri upravljanju javnih financ;
regarding budget support, EuropeAid should ensure that the specific conditions for payments are clearly defined and that Delegations’ reports provide a structured and formalised demonstration of progress achieved in public finance management;
toplo pozdravlja dejstvo, da je Evropska investicijska banka v postopku razrešnice za proračunsko leto 2009 Odboru Evropskega parlamenta za proračunski nadzor prvič predstavila letno poročilo o izvajanju investicijskega sklada in na pisna in ustna vprašanja poslancev podala obsežne odgovore; poziva Evropsko investicijsko banko, naj z odborom Parlamenta, ki bo pristojen za postopek razrešnice v prihodnjih letih, sklene okvirni sporazum, med drugim glede informacij, ki naj jih posreduje;
Very much welcomes the fact that, during the discharge procedure for the financial year 2009, the EIB presented, for the first time, its annual report on the implementation of the Investment Facility to Parliament's Committee on Budgetary Control and gave extensive replies to the written and oral questions from its members; requests the EIB to conclude a framework agreement with Parliament's committee responsible for the discharge procedure for the coming years, including the information to be provided by the EIB;
pričakuje potrditev Evropske investicijske banke, da med projekti, ki jih financira, in tistimi, ki jih financira Komisija, ne prihaja do podvajanj, in meni, da so nujno potrebne precejšnje izboljšave pri usklajevanju med Komisijo in Evropsko investicijsko banko, kot je to pred Odborom za proračunski nadzor 25. januarja 2011 dejal generalni direktor EIB za operacije zunaj Evropske unije; se sprašuje, ali naj se osebje Evropske investicijske banke napoti v delegacije Unije; pričakuje, da bo do konca septembra 2011 od obeh institucij prejel skupno poročilo o okrepitvi njunega sodelovanja in o dogovorjenih postopkih, vključno z analizo morebitne potrebe po napotitvi osebja Evropske investicijske banke v delegacije;
Expects the EIB to confirm that there is no overlap between projects it finances and those financed by the Commission and considers substantial improvements in coordination between the Commission and the EIB to be indispensable, as the EIB Director-General for Operations outside the European Union told the Committee on Budgetary Control on 25 January 2011; asks itself whether EIB staff should be posted to Union Delegations; expects to receive, by the end of September 2011, a combined report from both institutions on the reinforcement of their cooperation and the agreed procedures including an analysis of the possible need to post EIB staff in the Delegations;
poziva Evropsko investicijsko banko, naj izvede skrbni pregled in pred odobritvijo projektov preveri, ali je na lokalni ravni potekalo ustrezno javno posvetovanje o razvojnih vidikih projektov, kritih z jamstvi EU, med drugim o uspešnosti finančnih posrednikov pri uporabi posojil, ki jih je v skladu s temi vidiki odobrila Evropska investicijska banka; meni, da bi morala Evropska investicijska banka pri posojilih državam v razvoju izvajati stroge in obsežne skrbne preglede v skladu s standardnimi postopki, ki izhajajo iz najboljše mednarodne prakse na področju boja proti pranju denarja in financiranju terorizma;
Calls on the EIB to carry out thorough due diligence, verifying the presence of appropriate local public consultation, on development-related aspects of projects covered by the EU guarantee, prior to project approval, including the performance of financial intermediaries in using the loan granted by the EIB on these aspects; is of the opinion that, when it comes to lending in developing countries, the EIB should apply stringent enhanced due diligence in accordance with standardised procedures, following international best practices, concerning the fight against money laundering and the financing of terrorism;
znova poziva Evropsko investicijsko banko, naj se osredotoči na poročanje o rezultatih in naj predloži popolne, zadevne in objektivne informacije o izidih, postavljenih in doseženih ciljih, razlogih za možne nepravilnosti in izvedenih ocenah ter povzetek rezultatov ocenjevanja;
Calls once more on the EIB to focus its reporting on results and to present complete, relevant and objective information as regards outcomes, objectives set, objectives achieved and reasons for possible deviation, as well as evaluations carried out and a summary of evaluation results;
pozdravlja dejstvo, da je Evropska investicijska banka zdaj očitno bolj osredotočena na poročanje o rezultatih in da bo v letnem poročilu o investicijskem skladu za leto 2010, ki je v zaključni fazi, v primerjavi z letom 2009 namenjeno več pozornosti rezultatom; kot pozitiven korak ocenjuje sedanja prizadevanja Evropske investicijske banke za oblikovanje kazalnikov razvojnega uspeha, ki naj bi se začeli uporabljati v drugi polovici leta 2011;
Welcomes that the EIB now seems to be more committed to focusing on reporting on results, and that in the 2010 Annual Report on the Investment Facility which is currently being finalised, there will be more focus on results, compared to 2009; considers it a positive step forward that the EIB is currently working on development result indicators which should be ready for implementation towards the second half of 2011;
pričakuje, da bo prihodnje letno poročilo Evropske investicijske banke manj teoretično in bolj praktično, zlasti kar zadeva rezultate, ki so bili doseženi pri različnih programih, in ukrepe, ki so bili financirani iz investicijskega sklada;
Expects the next annual report of the EIB to be less theoretical and more practical, in particular on the results obtained by the various programs and actions financed by the Investment Facility;
poziva Evropsko investicijsko banko, naj Parlamentu posreduje dodatne informacije v zvezi s črnim seznamom goljufov, pri čemer naj se kot običajno zaščiti zaupnost primerov, ki so v teku; pozdravlja namero Evropske investicijske banke, da ustanovi enoto za boj proti goljufijam, in pričakuje, da bo redno seznanjen z napredkom na tem področju;
Calls on the EIB to forward to it additional information on the blacklist of fraudsters, whilst preserving the customary confidentiality of open cases; welcomes the EIB's stated aim of setting up an anti-fraud unit and expects to receive regular updates on progress made in establishing it;
je presenečen nad izjavo Evropske investicijske banke, v kateri je odkril, da v okviru njenih programov investicijskega sklada ne prihaja do nobenih goljufij;
Is surprised at the EIB's statement in which it found that no fraudulent practice exists in the context of EIB Investment Facility programmes;
meni, da je nujno treba izvesti obsežno revizijo vseh projektov v državah v razvoju, ki jih financira Evropska investicijska banka, pri čemer revizija ne sme biti omejena le na glavne projekte, ampak tudi na vsa proračunska sredstva in garancije, ki jih mora Evropska investicijska banka odpisati;
Considers it indispensable to conduct an overall audit of all projects in developing countries financed by the EIB, which should not be restricted to major projects but should also review all appropriations and guarantees the EIB must write off;
poziva Komisijo, naj tesno spremlja in nadzira izvajanje investicijskega sklada, da bi zagotovila izpolnjevanje ciljev, ki jih ima kot razvojni instrument, in naj o svojih ugotovitvah redno obvešča Odbor Evropskega parlamenta za proračunski nadzor.
Invites the Commission to monitor and control closely the implementation of the Investment Facility with a view to guaranteeing that it fulfils its objective as a development tool, and to inform Parliament's Committee on Budgetary Control on a regular basis of its findings.
Sklep Evropskega parlamenta z dne 10. maja 2011 o razrešnici glede izvrševanja proračuna Evropske agencije za zdravila za proračunsko leto 2009 ( C7-0233/2010 – 2010/2173(DEC) )
European Parliament decision of 10 May 2011 on discharge in respect of the implementation of the budget of the European Medicines Agency for the financial year 2009 ( C7-0233/2010 – 2010/2173(DEC) )
ob upoštevanju končnih letnih računovodskih izkazov Evropske agencije za zdravila za proračunsko leto 2009,
having regard to the final annual accounts of the European Medicines Agency for the financial year 2009,
ob upoštevanju poročila Računskega sodišča o letnih računovodskih izkazih Evropske agencije za zdravila za proračunsko leto 2009, skupaj z odgovori agencije UL C 338, 14.12.2010, str.
having regard to the Court of Auditors’ report on the annual accounts of the European Medicines Agency for the financial year 2009, together with the Agency's replies OJ C 338, 14.12.2010, p.
o postopkih Skupnosti za pridobitev dovoljenja za promet in nadzor zdravil za humano in veterinarsko uporabo ter o ustanovitvi Evropske agencije za zdravila, zlasti člena 68 te uredbe,
establishing a European Medicines Agency, and in particular Article 68 thereof,
ob upoštevanju poročila Odbora za proračunski nadzor in mnenja Odbora za okolje, javno zdravje in varnost hrane ( A7-0153/2011 ),
having regard to the report of the Committee on Budgetary Control and the opinion of the Committee on the Environment, Public Health and Food Safety ( A7-0153/2011 ),
odloži sprejetje sklepa o podelitvi razrešnice izvršnemu direktorju Evropske agencije za zdravila glede izvrševanja proračuna agencije za proračunsko leto 2009;
Postpones its decision on granting the Executive Director of the European Medicines Agency discharge in respect of the implementation of the Agency's budget for the financial year 2009;
Sklep Evropskega parlamenta z dne 10. maja 2011 o zaključku poslovnih knjig Evropske agencije za zdravila za proračunsko leto 2009 ( C7-0233/2010 – 2010/2173(DEC) )
European Parliament decision of 10 May 2011 on the closure of the accounts of the European Medicines Agency for the financial year 2009 ( C7-0233/2010 – 2010/2173(DEC) )
odloži zaključek poslovnih knjig Evropske agencije za zdravila za proračunsko leto 2009;
Postpones the closure of the accounts of the European Medicines Agency for the financial year 2009;
Resolucija Evropskega parlamenta z dne 10. maja 2011 s pripombami, ki so del sklepa o razrešnici glede izvrševanja proračuna Evropske agencije za zdravila za proračunsko leto 2009 ( C7-0233/2010 – 2010/2173(DEC) )
European Parliament resolution of 10 May 2011 with observations forming an integral part of its Decision on discharge in respect of the implementation of the budget of the European Medicines Agency for the financial year 2009 ( C7-0233/2010 – 2010/2173(DEC) )
ob upoštevanju letnega zaključnega računa Evropske agencije za zdravila za proračunsko leto 2009,
having regard to the final annual accounts of the European Medicines Agency (EMEA) for the financial year 2009,
ob upoštevanju letnega notranjega revizijskega poročila o Evropski agenciji za zdravila za leto 2009, ki ga je pripravila služba za notranjo revizijo;
having regard to the Internal Audit Service's Annual Internal Audit Report on the European Medicines Agency for 2009;
ker je Računsko sodišče v svojem poročilu o letnih računovodskih izkazih Evropske agencije za zdravila za proračunsko leto 2009 izdalo mnenje s pridržkom glede zakonitosti in pravilnosti z njimi povezanih transakcij,
whereas the Court of Auditors, in its report on the annual accounts of the European Medicines Agency for the financial year 2009, qualified its opinion on the legality and regularity of the underlying transactions,
ker je Parlament 5. maja 2010 izvršnemu direktorju Evropske agencije za zdravila podelil razrešnico glede izvrševanja proračuna agencije za proračunsko leto 2008 UL L 252, 25.9.2010, str.
whereas on 5 May 2010 Parliament granted the Executive Director of the Agency discharge for implementation of the Agency's budget for the financial year 2008 OJ L 252, 25.9.2010, p.
pozval agencijo, naj izboljša kakovost svojih postopkov javnih naročil, da bi odpravila pomanjkljivosti, ki jih je odkrilo Računsko sodišče (na primer v zvezi z uporabo metod vrednotenja za cenovna merila in nujnimi utemeljitvami izbire postopkov),
called on the Agency to improve the quality of its procurement procedures in order to put an end to the shortcomings identified by the Court of Auditors (for instance, as regards the application of evaluation methods for the price criteria and as regards the essential need for justifications for the choice of procedures),
ker je proračun agencije za 2009 znašal 194 000 000 EUR, kar je za 6,28 % več kot v proračunskem letu 2008,
whereas the budget of the Agency for 2009 was EUR 194 000 000, which is an increase of 6,28 % on the financial year 2008,
ker se proračun agencije financira iz proračuna Unij, ki predstavlja 18,52 % skupnih prejemkov v letu 2009, predvsem pa s taksami, ki jih plačujejo farmacevtske družbe, in ker se je posledično splošni prispevek Unije med letom 2008 in 2009 zmanjšal za 9,2 %;
whereas the Agency's budget is financed both from the Union budget, which accounted for 18,52 % of total revenue in 2009, and, to a greater extent, from fees paid by pharmaceutical companies, and whereas the Union's general contribution consequently decreased by 9,2 % between 2008 and 2009,
je resno zaskrbljen zaradi odgovorov agencije na pomembna vprašanja, ki sta jih zastavila Računsko sodišče in služba za notranjo revizijo, kot so:
Is seriously concerned with the Agency's replies to significant issues raised by the Court of Auditors and the Internal Audit Service (IAS), such as:
vodenje postopkov javnih naročil,
the management of procurement procedures,
pomanjkanje upoštevanja izvedbenih postopkov za ugotavljanje in upravljanje navzkrižja interesov uslužbencev in strokovnjakov agencije,
the lack of respect to implementing procedures regarding the identification and management of conflicts of interest for its staff and experts,
merila za zaposlovanje uslužbencev;
the criteria used for recruiting staff;
meni, da bi zlasti omenjeni vidiki lahko privedli do:
Considers, in particular, that the above-mentioned aspects could lead to the possibility of:
ponavljajočih se napak pri vodenju postopkov javnih naročil, kot so bile tiste, najdene v letu 2009, ki so predstavljale precejšen delež celotnega proračuna agencije in bi lahko ogrozile zakonitost in pravilnost transakcij, povezanih z računovodskimi izkazi agencije,
persistent errors in the management of procurement procedures, such as the ones found in 2009 corresponding to a significant amount of the Agency's total budget, which could compromise the legality and regularity of the transactions underlying the Agency's accounts,
morebitnih tveganj glede neodvisnosti strokovnjakov in uslužbencev, ki sodelujejo pri vrednotenju medicinskih proizvodov,
potential risks to the independence of experts/staff involved in the evaluation of medicinal products,
morebitnih pomanjkljivosti pri zaposlovanju uslužbencev in strokovnjakov, kar bi lahko privedlo ne samo do izločitve sposobnih kandidatov in/ali zaposlovanja manj sposobnih kandidatov, ampak ima lahko tudi negativne vplive na kakovost znanstvenega ocenjevanja agencije;
potential deficiencies in staff/experts’ recruitment which could not only lead to disqualification of competent candidates and/or recruitment of less qualified candidates but also might have negative effects on the quality of the Agency's scientific assessment work;
je zaskrbljen, ker je Računsko sodišče v postopkih javnih naročil odkrilo napake, ki predstavljajo precejšen delež skupnega proračuna agencije v proračunskem letu 2009; poudarja, da je Računsko sodišče že leta 2008 naletelo na pomanjkljivosti na tem področju, zlasti pri uporabi metod vrednotenja za merilo cene v utemeljitvah izbire postopkov;
Is concerned at the Court of Auditors’ findings of errors in the procurement procedures corresponding to a significant amount of the Agency's total budget for the financial year of 2009; stresses that in 2008 the Court of Auditors already identified shortcomings in this matter and, in particular, in the application of evaluation methods for the price criteria and in the justification for the choice of procedures;
še posebej poudarja, da je agencija v več postopkih javnih naročil za obsežne okvirne pogodbe za informacijsko tehnologijo v ocenjeni vrednosti 30 000 000 EUR leta 2009 naredila več napak pri začetku postopkov, kot so:
Acknowledges, in particular, that in a number of procedures for the procurement of large IT framework contracts of an estimated value of EUR 30 000 000 the Agency made several errors in 2009 at the moment of opening the procedure such as:
aritmetične napake pri vrednotenju meril za dodelitev naročila,
arithmetical errors in the evaluation of the award criteria,
neustrezna dokumentacija o vrednotenju člana izbirne komisije,
inappropriate documentation of the evaluation by a member of the evaluation committee,
nezadostni dokazi, da je bila metoda vrednotenja izbirnih meril uporabljena dosledno, zato je dopuščala različne interpretacije,
a lack of evidence that the evaluation method of the selection criteria had been applied consistently which was thus open to interpretation,
nezadostno preverjanje, s katerim naj bi zmanjšali tveganje napak pri začetku postopka s pogajanji, tako da zaradi napak pri uporabi meril za dodelitev naročila ni bil zagotovljen najboljši izkoristek sredstev;
a lack of checks to mitigate the risk of errors when opening a negotiated procedure which, in turn, did not guarantee that best value for money was achieved as a result of errors in the implementation of the award criteria;
ugotavlja tudi, da je v drugih dveh postopkih javnih naročil s pogajanji v zneskih 5 300 000 EUR in 4 000 000 EUR z enim samim dobaviteljem prišlo do več napak pri začetku postopka, na primer:
Acknowledges, also, that in two other negotiated procurements of EUR 5 300 000 and EUR 4 000 000 with a single supplier, several errors were again made at the moment of opening the procedure such as:
uradno povabilo za javni razpis ni bilo objavljeno,
no formal invitation to tender being issued,
podrobne tehnične specifikacije niso bile pripravljene vnaprej,
no detailed technical specifications being prepared in advance,
tehnične specifikacije pred začetkom pogajanj niso jasno opredeljevale vseh proizvodov, ki so predmet naročila,
technical specifications not clearly defining all the products to be purchased before the negotiation started,
izbirna komisija ni bila imenovana,
no evaluation committee being appointed,
poročilo o vrednotenju ni bilo pripravljeno,
no evaluation report being prepared;
zato ugotavlja, da agencija ni upoštevala različnih zahtev zadevnih predpisov o javnih naročilih;
Takes note therefore, that the Agency failed to comply with various requirements of the relevant procurement regulations;
ni pripravljen sprejeti dejstva, da agencija ni bila sposobna vzpostaviti nadzornega sistema, ki bi preprečil ali pravočasno zaznal omenjene ponavljajoče se napake, ki ogrožajo zakonitost in pravilnost transakcij, povezanih z računovodskimi izkazi agencije; glede na to poziva agencijo, naj poveča kakovost svojih postopkov javnih naročil in tako odpravi pomanjkljivosti, ki jih je odkrilo Računsko sodišče;
Is not ready to accept that the Agency was not able to put in place a control system to avoid or detect in time the above persistent errors which undermine the legality and regularity of the transaction underlying the Agency's accounts; accordingly, urges the Agency to improve the quality of its procurement procedures in order to put an end to the shortcomings identified by the Court of Auditors;
poziva agencijo, naj oblikuje večletni načrt oddaje javnih naročil, ki bi zagotovil strožje tehnične in postopkovne kontrole, in do 30. junija 2011 o tej zadevi poroča organu za podeljevanje razrešnice;
Calls on the Agency to set up a multiannual procurement plan which shall ensure stronger technical and procedural controls and to report to the discharge authority on this matter by 30 June 2011;
poziva agencijo, naj zagotovi, da se rezultati postopkov javnih naročil preverijo pred oddajo naročil; pričakuje, da se glede na ugotovitve Računskega sodišča vedno pripravijo podrobne tehnične specifikacije;
Calls on the Agency to ensure that the results of procurement procedures are verified before contracts are awarded; expects that detailed technical specifications shall always be prepared, in view of the Court of Auditors’ findings;
je zaskrbljen, ker je Računsko sodišče poročalo o prenosu proračunskih sredstev v znesku 19 500 000 EUR (38 % vseh obveznosti agencije) in da je bilo približno 14 800 000 EUR prenesenega zneska namenjenih dejavnostim, ki ob koncu leta še niso bile izvedene (oziroma v nekaterih primerih blagu, ki še ni bilo dobavljeno); poudarja, da je to stanje dokaz zamud pri izvajanju dejavnosti, ki se financirajo iz naslova II (nepremičnine, oprema in razni odhodki iz poslovanja) proračuna agencije, in priča, da agencija ne spoštuje proračunskega načela enoletnosti; je ocenil odgovor agencije v zvezi s pripombami in pozdravlja, da si agencija prizadeva zmanjšati obseg prenesenih sredstev; spodbuja agencijo, naj nadaljuje ta proces zaradi celovite uporabe načela enoletnosti;
Is concerned that the Court of Auditors has reported a carryover of EUR 19 500 000 (38 % of the Agency's commitments) and that approximately EUR 14 800 000 of this carryover was for activities as yet not implemented (or, in some cases, goods not received) at the year-end; stresses that this situation indicates delays in the implementation of activities financed from Title II (Buildings, equipment and miscellaneous operating expenditure activities) of the Agency's budget and that the Agency is not in accordance with the budgetary principle of annuality; has assessed the answer by the Agency on the observations and welcomes the efforts to reduce carryovers by the Agency; encourages the Agency to continue this process in order to apply fully the principle of annuality;
poziva agencijo, naj bolje usklajuje med svojimi finančnimi in znanstvenimi storitvami, da bo odpravila nesprejemljive, dolge zamude pri nalogih za izterjavo; ugotavlja, da so bile po poročilih Računskega sodišča pri dveh nalogih za izterjavo (226 200 EUR in 110 200 EUR) izmed desetih preverjenih zamude še posebej dolge (21 in 5 mesecev), kar je kršitev internih pravil agencije;
Calls on the Agency to ensure better coordination between its financial and scientific services in order to remedy the unacceptable, long delay for recovery orders; notes, in fact, that the Court of Auditors reported that two recovery orders (EUR 226 200 and EUR 110 200), out of ten tested, had a very long delay (21 and 5 months respectively), in breach of the Agency's internal rules;
poudarja, da se proračun Agencije financira tako s sredstvi iz proračuna Unije kot tudi s taksami, ki jih farmacevtska industrija plačuje za pridobitev ali podaljšanje dovoljenja za promet v Uniji; vendar ugotavlja, da prispevek iz proračuna Unije znaša le 18,7 % celotnega proračuna in se je z leti zmanjšal, v letu 2005 je na primer znašal 22,7 %; poudarja, da je celotni proračun agencije znašal 194 389 000 EUR;
Emphasises that the Agency's budget is financed both from the Union budget and fees paid by the pharmaceutical industry applying for or maintaining a Union marketing authorisation; notes, however, that the contribution from the Union budget represents only 18,7 % of the overall budget and has decreased over the years, for example, in 2005 the contribution represented 22,7 %; stresses that the overall budget available to the Agency was EUR 194 389 000;
Pogodbe o terminskih valutnih poslih
Foreign-exchange contracts